Form 4: BrightSpring Health Services Executive Receives Equity Grant

BrightSpring Health Services' President of PharMerica, Scott A. Greenwell, was granted 20,020 restricted stock units and 49,073 stock options.

Summary

• Scott A. Greenwell, President of PharMerica, a segment of BrightSpring Health Services, Inc. (BTSG), received an equity grant.
• On March 5, 2026, Greenwell was granted 20,020 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one share of common stock upon settlement.
• The RSUs will vest in three equal annual installments, commencing on January 25, 2027.
• Following this transaction, Greenwell beneficially owns 36,859 shares of common stock (including RSUs).
• Additionally, on March 5, 2026, Greenwell was granted 49,073 stock options.
• These stock options have an exercise price of $41.77 per share.
• The stock options will also vest in three equal annual installments, commencing on January 25, 2027.
• The stock options have an expiration date of March 5, 2036.
• Following this transaction, Greenwell beneficially owns 49,073 derivative securities (stock options).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It represents a routine executive compensation disclosure, which is a standard practice to align management incentives with shareholder interests, without indicating any immediate operational or financial performance changes.

Positives

• The equity grant aligns the interests of a key executive, Scott A. Greenwell, with those of shareholders, incentivizing long-term performance and value creation for BrightSpring Health Services.
• The vesting schedule over three years encourages executive retention and sustained focus on company growth and profitability.

Negatives

• The future settlement of RSUs and exercise of stock options could lead to a degree of share dilution, although this is a standard aspect of equity compensation plans.

Risks

• The value of the granted RSUs and stock options is directly tied to the future market performance of BrightSpring Health Services' common stock, exposing the executive to market volatility.
• Failure to meet vesting conditions (time-based in this case) would result in forfeiture of unvested equity, impacting the executive's total compensation.

Future Outlook

The equity grants, with their multi-year vesting schedules, indicate a long-term commitment from the executive to BrightSpring Health Services' performance and future growth, aligning compensation with sustained shareholder value creation.

Industry Context

StockSavvy.ai notes that the grant of restricted stock units and stock options to a senior executive is a standard practice in the healthcare services industry and across publicly traded companies. This form of compensation is widely used to attract, retain, and motivate key personnel by linking their financial incentives directly to the company's stock performance and long-term success.

Comparison to Industry Standards

• The structure of this equity grant, involving both RSUs and stock options with multi-year vesting, is consistent with common executive compensation practices observed in comparable healthcare service providers such as Encompass Health Corporation (EHC) or LHC Group (LHCG) prior to its acquisition. These companies frequently utilize a mix of time-based equity awards to foster executive retention and align interests with shareholders.
• The exercise price of $41.77 for the stock options is set at the market price on the grant date, which is a typical 'at-the-money' grant, standard across most industries for incentive options.

Stakeholder Impact

• Shareholders: The grant aims to align executive incentives with shareholder value creation, potentially leading to improved long-term performance. However, it also represents potential future dilution upon vesting and exercise.
• Employees: This grant is specific to a senior executive and does not directly impact the broader employee base, though it reflects the company's executive compensation philosophy.

Next Steps

• The RSUs and stock options will begin to vest in three equal annual installments starting January 25, 2027.
• The executive will continue to hold the beneficially owned common stock and derivative securities, subject to vesting schedules and market conditions.

Key Dates

Keywords

BrightSpring Health Services, BTSG, Scott A. Greenwell, Restricted Stock Units, RSUs, Stock Options, Equity Grant, Executive Compensation, Insider Transaction, Form 4, PharMerica